Medical Microbiology

Nematodes 54 5, 576
diagnosis 640
intestinalinfections
576 – 586
larvalinfections
601 – 605
tissueandvascularsys-
teminfections 587 – 601
seealsoHelminths;spe-
cificparasites
Neomycin 189
Nephelometry 122
Nephropathicaepidemica
(NE) 461 , 635
Nervoussysteminfections
64 4–6 46
encephalomyelitis
645 – 646
meningitis 27 3,
276 – 2 78, 644
seealsospecificinfections
Netilmicin 189
Neuraminidase 379
Neuraminidaseinhibitors
404
Neurocysticercosis
564 – 565
Neurosyphilis 321
Neurotoxins 15
botulinum 250
Nipahvirus465, 466
epidemiology 467
Nitrofural 192
Nitrofurans 192
Nitrofurantoin 192
Nitroimidazoles 192
Nocardia(nocardioses)
221 – 222, 272 – 273
asteroides 222
brasiliensis222, 652
clinicalpictures
272 – 273
pulmonarynocardio-
sis 273
surfacenocardiosis
273
systemicnocardiosis
273
culture 272
diagnosis 273
cardiovascularsystem
647
cutaneousinfection
652
eyeinfection656, 657
epidemiology 273
morphology 272
occurrence 272

pathogenesis 272 – 273

therapy 273

Nonanthropogenicevolu-

tion 203

Noncapsidviralproteins

(NCVP) 388

Noncytocidalinfection

393 – 394

Nonnucleosidereverse

transcriptaseinhibitors

(NNRTI) 454

Norfloxacin 189

Normalflora 24 – 25

NorthAmericanblasto-

mycosis 354 – 361

diagnosis 361

therapy 361

NorthAsiantickfever 332

Norwalkvirus439, 440

diagnosis 638

Nosema 539

Nosocomialinfections 1 0,

342 – 346

control 345 – 346

operationalmeasures

345

organizationalmea-

sures 345 – 346

structuralmeasures

346

definition 342

frequency 344

pathogens 342 – 345

sourcesofinfection 345

endogenousinfections

345

exogenousinfections

345

transmission 345

Nucleoid 14 8, 150 , 180

Nucleosidereversetran-

scriptaseinhibitors(NRTI)

40 4, 454

Nudemice 143

Nutrientmedia 16 4, 21 2,

213

Nystatin 356

&O

Oantigens 156 , 281

salmonellae282,

283 – 284

Vibriocholerae 297

OcularinfectionsseeEye

infections

Oeciacushirundinis 616

Ofloxacin 189

Omidazole 192

OmpA(outermembrane

proteinA) 155

Onchocercavolvulus

(onchocercosis)589,

590 – 591 , 594 – 596

clinicalmanifestations

594 – 595

eyechanges 595

reactionstoadult

parasites 595

reactionstomicrofi-

lariae 595

control 595 – 596

diagnosis 59 5, 652

eyeinfections 65 5, 657

epidemiology 594

lifecycle 594

occurrence 594

pathogenesis 594

prevention 595

therapy 595

Onchocercoma 595

Oncogenes395, 396

Oncoviruses 394 – 396,

448

genomestructure

394 – 395

replication 394 – 395

tumorinduction

395 – 396

withanoncogene 396

withoutanoncogene

395 – 396

Onychomycosis 374

Oophoritis 636

Operator 180

Operon 168 – 1 69, 180

anabolic 170

catabolic 170

transcriptionalregula-

tion 170

Ophthalmianeonatorum

276

Opisthorchiida 545

Opisthorchis(opisthorchio-

sis) 557 – 558

clinicalmanifestation

558

diagnosis 55 8,625, 641 ,

643

epidemiology 558

felineus543,556, 557

lifecycle 558

occurrence 557

prevention 558

therapy 558

Opisthorchis(opisthorchiosis)O 685

All rights reserved. Usage subject to terms and conditions of license

Kayser, Medical Microbiology © 2005 Thieme

All rights reserved. Usage subject to terms and conditions of license.